News

Therapeutic Solutions International Files Lawsuit in San Diego Superior Court to Obtain Identities of Certain Individuals or Entities

ELK CITY, Idaho–(BUSINESS WIRE)–Therapeutic Solutions International, Inc. (TSOI), announced the filing of a Civil Action in the Superior Court of the State of California for the County of San Diego to disclose the identities of […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

New Study Published in JAMA Neurology Affirms High Diagnostic Accuracy of ALZpath’s pTau217 Test in Identifying Amyloid and Tau in the Brain

ALZpath’s Blood-Based Test Delivers Accuracy Comparable to More Invasive and Expensive CSF-Based Tests, Reducing the Need for Confirmatory Testing By ~80% CARLSBAD, Calif., Jan. 22, 2024 /PRNewswire/ — ALZpath, Inc. (ALZpath), a leader in Alzheimer’s […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Bayer rolls out big changes; 2024’s biotech IPO queue; Dupixent’s ‘next big thing’; 23andMe’s struggle with dual identity; and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Viridian’s $150M offering; Surrozen scraps IBD drug candidate; Assembly ends deal with Indiana University

Plus, news about Vor Bio, Vaxxinity, Immatics and Certis Oncology: Viridian Therapeutics’ $150M public offering: The Waltham, MA-based biotech is selling about 7.1 million shares of its common stock at $21.00 per share, expecting to […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
News

Halozyme Announces argenx Received Approval in Japan for VYVDURA® (efgartigimod alfa and hyaluronidase-qvfc) Co-Formulated with ENHANZE® for Generalized Myasthenia Gravis

VYVDURA® provides patients with option for self-administration SAN DIEGO, Jan. 18, 2024 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme”) today announced that argenx received approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2023 Financial Results

Conference Call and Webcast Scheduled for Wednesday, February 7 SAN DIEGO, Jan. 17, 2024 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that it has scheduled its fourth quarter and year-end 2023 financial results […]

News

Thermo Fisher Scientific Unveils Industry’s First Off-the-Shelf Validated Software Solution to Automate Cell Therapy Manufacturing Workflows

CARLSBAD, Calif.–(BUSINESS WIRE)–To optimize clinical manufacturing processes for innovators developing breakthrough cell therapies, Thermo Fisher Scientific today announced the launch of the Gibco™ Cell Therapy Systems (CTS™) Cellmation™ Software, a first-of-its-kind automation solution designed to […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
News

Lifesaving Practicum

Nina Weisbrod, a second-year Master of Public Health (MPH) student in the Public Mental Health concentration at the Herbert Wertheim School of Public Health and Human Longevity Science has taken a unique approach to her […]